STOCKWATCH
·
Medical/Nursing Services
Quarterly ResultMay 8, 2026, 06:33 AM

AirSculpt Q1 Revenue Flat at $39.4M; Net Loss Narrows to $2.4M

AI Summary

AirSculpt Technologies reported flat revenue of $39.4 million for the first quarter of 2026, with a 1% increase on a same-center sales basis. The company narrowed its net loss to $2.4 million from $2.8 million in the prior year, despite a decrease in Adjusted EBITDA to $3.3 million. AirSculpt reaffirmed its full-year 2026 revenue and Adjusted EBITDA guidance, citing a solid start to the year and a strengthened balance sheet through debt reduction.

Key Highlights

  • Q1 2026 revenue was $39.4 million, flat compared to Q1 2025, with same-center sales up 1%.
  • Net loss for Q1 2026 narrowed to $2.4 million from $2.8 million in Q1 2025.
  • Adjusted EBITDA for Q1 2026 was $3.3 million, down from $3.8 million in Q1 2025.
  • Case volume increased 0.2% to 3,082, with same-center case growth of 1.1%.
  • AirSculpt reaffirmed its full-year 2026 revenue guidance of $151M-$157M and Adjusted EBITDA guidance of $15M-$17M.
  • The company paid down $11.4 million of debt and raised $14.6 million from an at-the-market offering program.
  • Cash and cash equivalents stood at $16.7 million as of March 31, 2026, with gross debt at $45.6 million.
AIRS
Medical/Nursing Services
Airsculpt Technologies, Inc.

Price Impact